Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients April 28, 2022 First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients First launches in Europe expected in H2 2022 Vifor...